NCT00683761

Timeline

Start date

Aug 1, 2008

Primary completion

Feb 1, 2010

Completion date

Apr 1, 2010

First posted

—

Last posted

—

Enrollment

64

Arms / groups

1 / —

Source

AACT · pre-existing

Sponsors

• TransMolecularLead sponsor
• Cedars-Sinai Medical CenterOverall official - principal investigator
• Columbia UniversityOverall official - principal investigator
• Emory UniversityOverall official - principal investigator
• Johns Hopkins UniversityOverall official - principal investigator
• Northwestern UniversityOverall official - principal investigator
• University of RochesterOverall official - principal investigator
• University of WashingtonOverall official - principal investigator
• University of VirginiaOverall official - principal investigator
• Vanderbilt UniversityOverall official - principal investigator
• Medical College of WisconsinOverall official - principal investigator
• University of ChicagoOverall official - principal investigator
• Cornell UniversityOverall official - principal investigator
• Tufts UniversityOverall official - principal investigator
• Baylor UniversityOverall official - principal investigator
• Harvard UniversityOverall official - principal investigator
• University of South FloridaOverall official - principal investigator
• University of Alabama, BirminghamOverall official - principal investigator

Drugs studied

• 131i-tm-601

Indications studied

• Astrocytoma
• Glioblastoma
• Glioma
• Oligodendroglioma